The Procter & Gamble
$143.95Change from previous close: −0.92%Absolute change: −$1.33
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $334.6B
- Enterprise value
- $360.67B
- P/E (trailing 12 months)
- 21.7
- Forward P/E
- 19.5
- PEG
- 3.72
- Price/book
- 6.27
- Price/sales
- 3.84
- EV/EBITDA
- 14.6
- EV/revenue
- 4.14
Profitability and growth
- Gross margin
- 50.9%
- Operating margin
- 22.1%
- Net margin
- 18.4%
- ROE
- 30.3%
- ROA
- 10.7%
- Revenue growth (year over year)
- 1.5%
- Earnings growth (year over year)
- -15.5%
Financial health
- Total cash
- $9.94B
- Total debt
- $35.02B
- Debt/equity
- 0.64
- Current ratio
- 0.68
- Quick ratio
- 0.41
Dividends
- Annual dividend per share
- $4.35
- Dividend yield
- 3.0%
- Payout ratio
- 64.3%
- Ex-dividend date
- July 24, 2026
Analysts and estimates
- Average price target
- $160.61
- Median price target
- $162.00
- High price target
- $186.00
- Low price target
- $143.00
- Number of analysts
- 23
- Consensus
- Buy
- Forward EPS
- $7.40
- EPS estimate, current year
- $6.98
Shares and trading
- Beta
- 0.38
- Average volume
- 8.57M
- Shares outstanding
- 2.32B
- Float
- 2.32B
- Institutional ownership
- 71.8%
- Insider ownership
- 0.1%
- Short interest (% of float)
- 1.0%
- Short ratio (days)
- 2.57